- Home
- CYTH vs AQMS Comparison
CYTH vs AQMS Comparison
Compare CYTH & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTH
- AQMS
- Stock Information
- Founded
- CYTH 1990
- AQMS 2014
- Country
- CYTH United States
- AQMS United States
- Employees
- CYTH N/A
- AQMS N/A
- Industry
- CYTH Biotechnology: Pharmaceutical Preparations
- AQMS Metal Fabrications
- Sector
- CYTH Health Care
- AQMS Industrials
- Exchange
- CYTH Nasdaq
- AQMS Nasdaq
- Market Cap
- CYTH 20.4M
- AQMS 18.0M
- IPO Year
- CYTH N/A
- AQMS 2015
- Fundamental
- Price
- CYTH $0.69
- AQMS $2.10
- Analyst Decision
- CYTH Buy
- AQMS Strong Buy
- Analyst Count
- CYTH 3
- AQMS 2
- Target Price
- CYTH $0.95
- AQMS $30.00
- AVG Volume (30 Days)
- CYTH 21.2K
- AQMS 106.9K
- Earning Date
- CYTH 11-14-2024
- AQMS 11-14-2024
- Dividend Yield
- CYTH N/A
- AQMS N/A
- EPS Growth
- CYTH N/A
- AQMS N/A
- EPS
- CYTH N/A
- AQMS N/A
- Revenue
- CYTH $870,725.00
- AQMS N/A
- Revenue This Year
- CYTH N/A
- AQMS N/A
- Revenue Next Year
- CYTH $24.49
- AQMS N/A
- P/E Ratio
- CYTH N/A
- AQMS N/A
- Revenue Growth
- CYTH N/A
- AQMS 525.00
- 52 Week Low
- CYTH $0.59
- AQMS $1.33
- 52 Week High
- CYTH $2.12
- AQMS $18.80
- Technical
- Relative Strength Index (RSI)
- CYTH 47.10
- AQMS 18.44
- Support Level
- CYTH $0.61
- AQMS $1.33
- Resistance Level
- CYTH $0.77
- AQMS $2.15
- Average True Range (ATR)
- CYTH 0.05
- AQMS 0.26
- MACD
- CYTH -0.00
- AQMS -0.06
- Stochastic Oscillator
- CYTH 55.63
- AQMS 7.48
About CYTH Cyclo Therapeutics Inc.
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.